ForumIAS LATEST
- 04 June | MGP Strategy Series | GS Paper 4 (Ethics) with AIR 7 A.R. Rajah Mohaideen Click Here to register for the session →
- 04 June | GS Advance Program begins from 4th June 2026 | First 2 classes open to all Click Here to register for the event →
- 05 June | MGP Strategy Series | GS Paper 3 Strategy Session with AIR 406 Mannat Luthra Click Here to register for the session
- 06 June | Open Orientation on Essay Guidance Program (EGP 2026) Click Here to register →
- 07 June | Open Orientation for Current Affairs for Mains 2026 Click Here to register →
- 07 June | Sociology Optional Strategy Session with AIR 10 Ujjwal Priyank Click Here to register →
News: Union Minister for Health and Family Welfare launched the second phase of “Thalassemia Bal Sewa Yojna” for the underprivileged Thalassemic patients.
Facts:
- Thalassemia Bal Sewa Yojna: It was launched in 2017 with the aim to provide a one-time cure opportunity for Haemoglobinopathies like Thalassaemia and Sickle Cell Disease for patients who have a matched family donor.
- Funded by: The scheme is a Coal India CSR funded Hematopoietic Stem Cell Transplantation(HSCT) program.
- Beneficiary: The initiative aims to provide financial assistance to a total of 200 patients by providing a package cost not exceeding Rs. 10 lakhs per HSCT.
Additional Facts:
- Thalassemia: It is a chronic and genetic blood disorder due to which a patient’s body cannot make enough hemoglobin leading to anemia.This disease is passed from parents to children through genes and people suffering from it require blood transfusions to survive.
- Hematopoietic stem-cell transplantation(HSCT): It is the transplantation of multipotent hematopoietic stem cells usually derived from bone marrow, peripheral blood, or umbilical cord blood.
- It may be autologous (the patient’s own stem cells are used), allogeneic (the stem cells come from a donor) or syngeneic (from an identical twin).
- It is most often performed for patients with certain cancers of the blood, thalassemia or bone marrow such as multiple myeloma or leukemia.
